Invivyd to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Invivyd (Nasdaq: IVVD) announced its participation in two upcoming investor conferences in New York. The company will participate in fireside chats at the Cantor Global Healthcare Conference on September 3, 2025, at 2:10 PM ET, and at the H.C. Wainwright 27th Annual Global Investment Conference on September 8, 2025, at 12:00 PM ET.

The presentations will be available via live webcasts on the company's investor website and archived for approximately 30 days. Management will also host investor meetings during both conferences.

News Market Reaction

-15.44%

33 alerts

-15.44% News Effect

+19.9% Peak Tracked

-19.0% Trough Tracked

-$38M Valuation Impact

$211M Market Cap

1.2x Rel. Volume

On the day this news was published, IVVD declined 15.44%, reflecting a significant negative market reaction. Argus tracked a peak move of +19.9% during that session. Argus tracked a trough of -19.0% from its starting point during tracking. Our momentum scanner triggered 33 alerts that day, indicating elevated trading interest and price volatility. This price movement removed approximately $38M from the company's valuation, bringing the market cap to $211M at that time.

Data tracked by StockTitan Argus on the day of publication.

WALTHAM, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced that it will present at the following investor conferences:

Cantor Global Healthcare Conference 2025
Fireside Chat Date: Wednesday, September 3, 2025
Fireside Chat Time: 2:10 PM ET
Location: New York, NY

H.C. Wainwright 27th Annual Global Investment Conference
Fireside Chat Date: Monday, September 8, 2025
Fireside Chat Time: 12:00 PM ET
Location: New York, NY

Live webcasts of the fireside chats will be available in the investor section of the company’s website at investors.invivyd.com and will be archived for approximately 30 days following each event.

In addition to the fireside chats, the management team will host investor meetings at the conferences. Investors participating in the conferences who are interested in meeting with Invivyd management should contact their Cantor or H.C. Wainwright representative.

About Invivyd

Invivyd, Inc. (Nasdaq: IVVD) is a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, beginning with SARS-CoV-2. Invivyd deploys a proprietary integrated technology platform unique in the industry designed to assess, monitor, develop, and adapt to create best in class antibodies. In March 2024, Invivyd received emergency use authorization (EUA) from the U.S. FDA for a monoclonal antibody (mAb) in its pipeline of innovative antibody candidates. Visit https://invivyd.com/ to learn more.

Contacts:

Media Relations
(781) 208-1747
media@invivyd.com

Investor Relations
(781) 208-1747
investors@invivyd.com

FAQ

When is Invivyd (IVVD) presenting at the Cantor Global Healthcare Conference 2025?

Invivyd will present at the Cantor Global Healthcare Conference on Wednesday, September 3, 2025 at 2:10 PM ET in New York.

What time is Invivyd's presentation at the H.C. Wainwright Conference 2025?

Invivyd will present at the H.C. Wainwright Conference on Monday, September 8, 2025 at 12:00 PM ET in New York.

How can investors access Invivyd's conference presentations?

Investors can access the live webcasts of the fireside chats through Invivyd's investor website at investors.invivyd.com. The presentations will be archived for approximately 30 days.

How can investors schedule meetings with Invivyd management at these conferences?

Investors participating in the conferences who want to meet with Invivyd management should contact their Cantor or H.C. Wainwright representative to schedule a meeting.